arthritis help
filed in Uncategorized on Aug.28, 2011
A drug used today to treat rheumatoid arthritis might be effective in treating asthma symptoms after two genetic variants have been found to increase asthma susceptibility, researchers from the Queensland Institute of Medical Research, Brisbane, Australia and others from around the world reported in The Lancet. The scientists found that cytokines - genes associated with signalling molecules that are involved in how the immune system functions - are involved in the development of asthma.
The authors explained that the causes of asthma have for long been poorly understood, in spite of several attempts to locate the genetic variants. Some recent GWAS (genome-wide associated studies) have only managed to locate some candidate genes which appear to have a slight effect on asthma risk. They have not fully explained the heritability of asthma, which leads doctors and scientists to believe that many genetic variations are involved.
Manuel Ferreira and an international team of experts set out to determine what genetic variations might be responsible for higher asthma risk by carefully examining all current GWAS and expanding on them.
They compared the genomes of thousands of asthma patients with individuals who do not have asthma across several populations and identified two genetic mutations that were strongly linked to asthma risk.
The genetic variants were:
- rs4129267 in the interleukin-6 receptor (IL6R) gene, and
- rs7130588 on chromosome 11q13.5
The drug tocilizumab is an example of a medication that blocks the receptor. It is already approved for rheumatoid arthritis treatment.
A high proportion of atopic (allergic) asthma patients were found to have the rs7130588 variant on chromosome 11q13.5. Interestingly, it was correlated with a nearby variant which has been recently associated with atopic dermatitis risk.
The authors believe that a gene in this region is involved in the development of allergic sensitisation, which raises allergic asthma risk.
The authors wrote:
"At this stage it is unclear which gene underlies the association with 11q13.5. Given that no specific gene in this region has been directly implicated in allergic disease previou. sly, further characterisation of this region of association is likely to discover novel molecular mechanisms involved in the causality of eczema, atopy, and asthma."
So far, no single genetic cause has been located which is responsible for over 1% of asthma heritability, the authors added. Their findings demonstrate that asthma is a complex condition, and most likely several genes of small effect combine and interact with environmental risk factors in driving asthma risk.
The scientists concluded:
"Our results are consistent with the contribution of hundreds or potentially thousands of variants with weak effects on asthma risk, which can be identified through larger GWAS as already shown with other diseases."
Kathleen Barnes, from Johns Hopkins University, Baltimore, USA, in a Comment in the same journal wrote:
"Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma."
Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
- Additional
- References
- Citations
Here's a fine old FDA public service announcement in which Raymond Massey gravely warns America to steer clear of bizarro quack devices that claim to treat arthritis with z-rays or cure cancer with music.
‘Help Stamp Out Quackery’, 1950s Maybe it's because I spent a lot of time with my grandmother and her house was full of them.. It's a beautiful painting but it's just too depressing to hang anywhere.There is a subcategory of folk.....
‘Help Stamp Out Quackery’, 1950s .5Interleukin 6 (IL-6) is a cytokine. The scientists found that cytokines - genes associated with signalling molecules that are involved in how the immune system functions - are involved in the development of allergic sensitisation, which raises allergic asthma risk.Manuel Ferreira and an international team of experts set out to determine what genetic variations might be responsible for higher asthma risk by carefully examining all current GWAS and expanding on them.The authors explained that the causes of asthma have for long been poorly understood, in spite One of my favorite paintings was done in 1962 by Bill Dodge. She favors animal prints, and I found one that depicts leopards and gave it to her for her birthday. One of my favorites that she had was done by John Roeder. I have a friend who collects these and I found one of a woman reclining in a hammock.The painting that has touched me the most features a sad little girl and is called A Letter From My Mother. I don't know whose smile is bigger, the one in the painting or the one on my face every time I look at it. Still, they are a joy to behold. She looked so relaxed, that I could imagine what it felt like to lie there myself. It's a beautiful painting but it's just too depressing to hang anywhere. It's pretty funny to me that when we were growing up, she'd cry because she wasn't allowed to play football with the boys and I used to tease her relentlessly and pull her pigtails whenever I got the chance. If she could kick the ball they way she liked to kick me in the knee, I'd see to it she played for my team every time.. It's called First Trolley to Van Nuys and shows the center of a town filled with people. It is done in vibrant colors and also depicts the buildings in the market like an ice cream parlor and the Hotel Van Nuys.One of the most famous American artists is Thomas Chambers.I have loved folk art paintings since I was a child. I saw a painting he did of a fishing scene but I chose not to buy it. I spent a lot of time playing in my tree house, that the trees in the picture appealedrthritis help athritis help arhritis help artritis help arthitis help arthrtis help arthriis help arthrits help arthriti help arthritis elp arthritis hlp arthritis hep arthritis hel srthritis help aethritis help atthritis help arrhritis help aryhritis help artgritis help artjritis help artheitis help arthtitis help arthrutis help arthrotis help arthriris help arthriyis help arthritus help arthritos help arthritia help arthritid help arthritis gelp arthritis jelp arthritis hwlp arthritis hrlp arthritis hekp arthritis helo
rathritis help atrhritis help arhtritis help artrhitis help arthirtis help arthrtiis help arthriits help arthritsi help arthriti shelp arthritis ehlp arthritis hlep arthritis hepl arthritis hel aarthritis help arrthritis help artthritis help arthhritis help arthrritis help arthriitis help arthrittis help arthritiis help arthritiss help arthritis hhelp arthritis heelp arthritis hellp arthritis helpp
A drug used today to treat rheumatoid arthritis might be effective in treating asthma symptoms after two genetic variants have been found to increase asthma susceptibility, researchers from the Queensland Institute of Medical Research, Brisbane, Australia and others from around the world reported in The Lancet. The scientists found that cytokines - genes associated with signalling molecules that are involved in how the immune system functions - are involved in the development of asthma.
The authors explained that the causes of asthma have for long been poorly understood, in spite of several attempts to locate the genetic variants. Some recent GWAS (genome-wide associated studies) have only managed to locate some candidate genes which appear to have a slight effect on asthma risk. They have not fully explained the heritability of asthma, which leads doctors and scientists to believe that many genetic variations are involved.
Manuel Ferreira and an international team of experts set out to determine what genetic variations might be responsible for higher asthma risk by carefully examining all current GWAS and expanding on them.
They compared the genomes of thousands of asthma patients with individuals who do not have asthma across several populations and identified two genetic mutations that were strongly linked to asthma risk.
The genetic variants were:
- rs4129267 in the interleukin-6 receptor (IL6R) gene, and
- rs7130588 on chromosome 11q13.5
The drug tocilizumab is an example of a medication that blocks the receptor. It is already approved for rheumatoid arthritis treatment.
A high proportion of atopic (allergic) asthma patients were found to have the rs7130588 variant on chromosome 11q13.5. Interestingly, it was correlated with a nearby variant which has been recently associated with atopic dermatitis risk.
The authors believe that a gene in this region is involved in the development of allergic sensitisation, which raises allergic asthma risk.
The authors wrote:
"At this stage it is unclear which gene underlies the association with 11q13.5. Given that no specific gene in this region has been directly implicated in allergic disease previou. sly, further characterisation of this region of association is likely to discover novel molecular mechanisms involved in the causality of eczema, atopy, and asthma."
So far, no single genetic cause has been located which is responsible for over 1% of asthma heritability, the authors added. Their findings demonstrate that asthma is a complex condition, and most likely several genes of small effect combine and interact with environmental risk factors in driving asthma risk.
The scientists concluded:
"Our results are consistent with the contribution of hundreds or potentially thousands of variants with weak effects on asthma risk, which can be identified through larger GWAS as already shown with other diseases."
Kathleen Barnes, from Johns Hopkins University, Baltimore, USA, in a Comment in the same journal wrote:
"Success in the validation of various candidates (and their pathways) that are already on the asthma shortlist of potential causal genes, and the biological insight to be gained from the novel findings in this report are grounds for optimism in the continuation of the GWAS approach. Combination of GWAS with next-generation technologies will undoubtedly further help to disentangle the molecular underpinnings of complex traits such as asthma."
Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
- Additional
- References
- Citations
Here's a fine old FDA public service announcement in which Raymond Massey gravely warns America to steer clear of bizarro quack devices that claim to treat arthritis with z-rays or cure cancer with music.
‘Help Stamp Out Quackery’, 1950s